Bronstein, Gewirtz & Grossman, LLC: Encouraging Growth in Pagaya Technologies – A Detailed Discussion

Bronstein, Gewirtz & Grossman, LLC Investigates Potential Claims Against Pagaya Technologies Ltd. New York, NY, February 12, 2025 – Bronstein, Gewirtz & Grossman, LLC is currently investigating potential securities fraud class action lawsuits on behalf of purchasers of Pagaya Technologies Ltd. (Pagaya or the Company) (NASDAQ: PGY). The investigation concerns possible violations of the Securities…

Read More

Charmingly Eccentric: Google’s 2025 Diversity Goals and the Impact of DEI on Technology

Charmingly Eccentric: Embracing Diversity in Silicon Valley The Silicon Valley giant’s Diversity Programs The Silicon Valley giant, known for its innovative technology and forward-thinking initiatives, recently announced that it is reviewing its diversity programs and initiatives. The company stated that it is dedicated to creating a more inclusive and diverse work environment, and is committed…

Read More

“Meridian Corporation Announces Strong Fourth Quarter 2024 Results and Quarterly Dividend of $0.125 per Share”

Meridian Corporation Reports Strong Financial Results Overview Meridian Corporation (Nasdaq: MRBK) has announced their financial results for the year 2024, reporting a net income of $16.3 million and diluted earnings per common share of $1.45. This represents a significant increase from the previous year, indicating strong performance and growth for the company. Income For the…

Read More

Regulus Therapeutics: Shining Bright at Oppenheimer’s 35th Healthcare Conference!

Regulus Therapeutics: A Peek into the World of MicroRNAs and Their Upcoming Presentation at the Oppenheimer Conference Regulus Therapeutics Inc., a trailblazing biopharmaceutical company, is set to make waves in the healthcare industry once again. On Tuesday, February 11, members of Regulus’ esteemed management team will grace the stage at the Oppenheimer 35th Annual Healthcare…

Read More